CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-27 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −1,100 | $20.00 | $22K | 2,711,198 |
| 2026-07-22 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −2,448 | $20.00 | $49K | 2,712,298 |
| 2026-07-21 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $20.02 | $1.0M | 2,714,746 |
| 2026-07-20 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −43,700 | $20.09 | $878K | 2,764,746 |
| 2026-07-15 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −16,105 | $20.01 | $322K | 2,808,446 |
| 2026-07-10 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −68,289 | $20.02 | $1.4M | 2,774,893 |
| 2026-07-09 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −33,936 | $20.01 | $679K | 2,843,182 |
| 2026-07-01 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −47,775 | $20.03 | $957K | 2,877,118 |
| 2026-06-22 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −39,120 | $22.04 | $862K | 1,115,435 |
| 2026-06-18 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −2,794 | $19.60 | $55K | 1,154,555 |
| 2026-06-17 | BVF PARTNERS L P/IL Director | Grant or award · Option to Buy | +22,195 | 22,195 | ||
| 2026-06-17 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −15,082 | $19.68 | $297K | 1,157,349 |
| 2026-06-17 | Phillips Andrew John Director | Grant or award · Option to Buy | +22,195 | 22,195 | ||
| 2026-06-17 | Loy Spike Director | Grant or award · Option to Buy | +22,195 | 22,195 | ||
| 2026-06-17 | Moukheibir Catherine Director | Grant or award · Option to Buy | +22,195 | 22,195 | ||
| 2026-06-17 | Xavier Ramnik Director | Grant or award · Option to Buy | +22,195 | 22,195 | ||
| 2026-06-17 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $19.43 | $972K | 2,824,551 |
| 2026-06-16 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $18.70 | $935K | 2,874,551 |
| 2026-06-15 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $18.89 | $945K | 2,924,551 |
| 2026-05-11 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −13,653 | $20.02 | $273K | 1,172,431 |
Page 1 of 10 · 184 trades